The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
Abstract
PURPOSE: To evaluate the efficacy and toxicity of Hyper-CVAD (fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone), a dose-intensive regimen, in adult acute lymphocytic leukemia (ALL). PATIENTS AND METHODS: Adults with newly diagnosed ALL referred since 1992 were entered onto the study; treatment was initiated in 204 patients between 1992 and January 1998. No exclusions were made because of older age, poor performance status, organ dysfunction, or active infection. Median age was 39.5 years; 37% were at least 50 years old. Mature B-cell disease (Burkitt type) was present in 9%, T-cell disease in 17%. Leukocytosis of more than 30 × 10 9/L was found in 26%, Philadelphia chromosome–positive disease in 16% (20% of patients with assessable metaphases), CNS leukemia at the time of diagnosis in 7%, and a mediastinal mass in 7%. Treatment consisted of four cycles of Hyper-CVAD alternating with four cycles of high-dose methotrexate (MTX) and cytarabine therapy, together with intrathecal CNS prophylaxis and supportive care with antibiotic prophylaxis and granulocyte colony-stimulating factor therapy. Maintenance in patients with nonmature B-cell ALL included 2 years of treatment with mercaptopurine, MTX, vincristine, and prednisone (POMP). RESULTS: Overall, 185 patients (91%) achieved complete remission (CR) and 12 (6%) died during induction therapy. Estimated 5-year survival and 5-year CR rates were 39% and 38%, respectively. The incidence of CNS relapse was low (4%). Compared with 222 patients treated with vincristine, doxorubicin, and dexamethasone (VAD) regimens, our patients had a better CR rate (91% v 75%, P < .01) and CR rate after one course (74% v 55%, P < .01) and better survival (P < .01), and a smaller percentage had more than 5% day 14 blasts (34% v 48%, P = .01). Previous prognostic models remained predictive for outcome with Hyper-CVAD therapy. CONCLUSION: Hyper-CVAD therapy is superior to our previous regimens and should be compared with established regimens in adult ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
International System for Human Cytogenetic Nomenclature
National Cancer Institute (2020) · Definitions · doi:10.32388/78qroa · Cited by 6,840
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
A note on quantifying follow-up in studies of failure time
Schemper, M., & Smith, T. L. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(96)00075-x · Cited by 2,575
Self-citationMartingale-based residuals for survival models
THERNEAU, T. M., GRAMBSCH, P. M., & FLEMING, T. R. (1990) · Biometrika · doi:10.1093/biomet/77.1.147 · Cited by 1,099
Pui, C.-H., & Evans, W. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390907 · Cited by 832
Larson, R., Dodge, R., Burns, C., Lee, E., Stone, R., Schulman, P., Duggan, D., Davey, F., Sobol, R., & Frankel, Sr. (1995) · Blood · doi:10.1182/blood.v85.8.2025.bloodjournal8582025 · Cited by 626
Reiter, A., Schrappe, M., Ludwig, W., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., & Niethammer, D. (1994) · Blood · doi:10.1182/blood.v84.9.3122.3122 · Cited by 621
Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
Evans, W. E., Relling, M. V., Rodman, J. H., Crom, W. R., Boyett, J. M., & Pui, C.-H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380803 · Cited by 492
Clavell, L. A., Gelber, R. D., Cohen, H. J., Hitchcock-Bryan, S., Cassady, J. R., Tarbell, N. J., Blattner, S. R., Tantravahi, R., Leavitt, P., & Sallan, S. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151101 · Cited by 416
Rivera, G. K., Pui, C.-H., Abromowitch, M., Mirro, J., Ochs, J. S., Look, A. T., Murphy, S. B., Dahl, G. V., Kalwinsky, D. K., Simone, J. V., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90733-6 · Cited by 376
Self-citationComparative pharmacokinetic studies of three asparaginase preparations.
Asselin, B. L., Whitin, J. C., Coppola, D. J., Rupp, I. P., Sallan, S. E., & Cohen, H. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1780 · Cited by 333
Improved outcome in adult B-cell acute lymphoblastic leukemia
Hoelzer, D., Ludwig, W., Thiel, E., Gassmann, W., Loffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., et al. (1996) · Blood · doi:10.1182/blood.v87.2.495.bloodjournal872495 · Cited by 314
Westbrook, C., Hooberman, A., Spino, C., Dodge, R., Larson, R., Davey, F., Wurster- Hill, D., Sobol, R., Schiffer, C., & Bloomfield, C. (1992) · Blood · doi:10.1182/blood.v80.12.2983.2983 · Cited by 274
Larson, R. A., Dodge, R. K., LINKER, C. A., Stone, R. M., Powell, B. L., Lee, E. J., Schulman, P., Davey, F. R., Frankel, S. R., Bloomfield, C. D., et al. (1998) · PubMed · doi:10.1182/blood.v92.5.1556 · Cited by 269
Murphy, S. B., Bowman, W. P., Abromowitch, M., Mirro, J., Ochs, J., Rivera, G., Pui, C. H., Fairclough, D., & Berard, C. W. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.12.1732 · Cited by 267
Self-citationTubergen, D. G., Gilchrist, G. S., O'Brien, R. T., Coccia, P. F., Sather, H. N., Waskerwitz, M. J., & Hammond, G. D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.527 · Cited by 221
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
Keating, M. J., Holmes, R., Lerner, S., & Ho, D. H. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309149129 · Cited by 217
Self-citationPui, C.-H., Mahmoud, H. H., Rivera, G. K., Hancock, M. L., Sandlund, J. T., Behm, F. G., Head, D. R., Relling, M. V., Ribeiro, R. C., Rubnitz, J. E., et al. (1998) · Blood · doi:10.1182/blood.v92.2.411 · Cited by 209
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Kitanaka, A., Pui, C., McNinch, L., Evans, W., Raimondi, S., Behm, F., Arico, M., & Campana, D. (1996) · Blood · doi:10.1182/blood.v87.3.1140.bloodjournal8731140 · Cited by 208
Clinical Importance of Myeloid-Antigen Expression in Acute Lymphoblastic Leukemia of Childhood
Wiersma, S. R., Ortega, J. A., Sobel, E. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241204 · Cited by 185
Beran, M., Cao, X., Estrov, Z., Jeha, S., Jin, G., O'Brien, S. M., Talpaz, M., Arlinghaus, R. B., Lydon, N., & Kantarjian, H. M. (1998) · PubMed · Cited by 176
Self-citationGaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., & Gee, T. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.6.1014 · Cited by 170
Self-citationBowman, W. P., Shuster, J. J., Cook, B., Griffin, T., Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1252 · Cited by 166
Self-citationSchmiegelow, K., Schrøder, H. D., Gustafsson, G., Kristinsson, J. A., Glomstein, A., Salmi, T., & WRANNE, L. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.345 · Cited by 141
Kantarjian, H., Talpaz, M., Dhingra, K., Estey, E. H., Keating, M. J., Ku, S., Trujillo, J., Huh, Y. O., Stass, S. A., & Kurzrock, R. (1991) · Blood · doi:10.1182/blood.v78.9.2411.2411 · Cited by 133
Self-citationCampana, D., Coustan‐Smith, E., Manabe, A., Buschle, M., Raimondi, S., Behm, F., Ashmun, R. A., Aricò, M., Biondi, A., & Pui, C. (1993) · Blood · doi:10.1182/blood.v81.4.1025.1025 · Cited by 127
Camitta, B. M., Leventhal, B. G., Lauer, S. J., Shuster, J. J., Adair, S. E., Casper, J. T., Civin, C. I., Graham, M. M., Mahoney, D. H., & Munoz, L. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1539 · Cited by 95
Pui, C., Simone, J. V., Hancock, M., We, E., Dl, W., Wp, B., Dahl, G. V. H., Rk, D., Ochs, J., & Abromowitch, M. (1992) · PubMed · Cited by 74
Gala, J., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J., Philippe, M., & Martiat, P. (1994) · Annals of Hematology · doi:10.1007/bf01757343 · Cited by 56
HyperCVAD for VAD-resistant multiple myeloma
Dimopoulos, M. A., Weber, D., Kantarjian, H. M., Delasalle, K. B., & Alexanian, R. (1996) · American Journal of Hematology · Cited by 44
Self-citationIntravenous mercaptopurine: life begins at 40.
Pinkel, D. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1826 · Cited by 43
Cited by
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005930 · Cited by 2,063
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
Terwilliger, T., & Abdul-Hay, M. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.53 · Cited by 1,288
Pui, C.-H., Relling, M. V., & Downing, J. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmra023001 · Cited by 1,185
Cytogenetics in acute leukemia
Mrózek, K., Heerema, N. A., & Bloomfield, C. D. (2004) · Blood Reviews · doi:10.1016/s0268-960x(03)00040-7 · Cited by 659
Metadata
- Authors
- Kantarjian, H. M., O’Brien, S., Smith, T. L., Cortes, J., Giles, F. J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C. S., Keating, M. J., Murphy, S., & Freireich, E. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-02-01
- Volume
- 18
- Issue
- 3
- Pages
- 547-547
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1862517694
- Cited by
- 796
- References
- 36
- FWCI
- 40.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.